Management
Team
Philippe Deschamps
CEO
Luc Mainville, MBA
SVP, CFO
Guy Paul Allard
VP, Legal Affairs and Corporate Secretary
Dr. Jonathan Sackier
SVP, Medical Affairs
-
Philippe Deschamps
CEO
Philippe Deschamps is an experienced Healthcare Executive who has served as CEO of three companies over the last 20 years. The depth of his expertise stems from his 36 years in the Life Sciences industry spent at Bristol Myers Squibb, GSW Worldwide, a leading healthcare commercialization company, and Helius Medical Technologies, a NeuroTech company. As co-founder and CEO of Helius Medical Technologies, Mr. Deschamps took the company public on both the CSE, TSX and NASDAQ stock exchanges and raised $100M to commercialize their Neurotech product PoNS. The product gained approval in both Canada and the US.
At GSW, Mr. Deschamps was President and CEO and was responsible for the GSW expansion into a Worldwide operation to support the globalization of Pharma. Under his watch, revenues grew from $30M from 2 US offices in 2002 to $160M in annual revenue from 16 countries in 2011. During his tenure, he stayed heavily involved with the company's top clients and developed innovative partnerships to increase performance and save money.
Before joining GSW Worldwide, Mr. Deschamps served as director of neuroscience marketing at Bristol- Myers Squibb (BMS) in Princeton, N.J., where he oversaw the company's neuroscience products including BUSPAR SERZONE and STADOL NS. He also held several marketing positions in the neuroscience, pain and metabolic therapeutic areas throughout his career. Mr. Deschamps has a BSc. from the University of Ottawa in Canada.
-
Luc Mainville, MBA
SVP, CFO
Mr. Mainville has an accomplished history of financial and operational leadership successes within the life science industry. In an executive management career that spans more than 20 years, he has led or been integrally involved in four go-public transactions, completed more than 20 public financings, and managed more than 50 licensing, merger and acquisition, and sale transactions.
Mr. Mainville also serves as Senior Vice President and CFO for Valeo Pharma. His earlier experience includes senior management and financial roles with various life science companies, including Acerus Pharma, Cardiome Pharma, Neopharm Labs and LAB Research Inc. Prior to launching his career in the life science industry, Mr. Mainville was a Partner at KPMG LLP. Mr. Mainville has also served as Vice-Chairman of BIOTECanada and holds an MBA from McGill University.
-
Guy Paul Allard
VP, Legal Affairs and Corporate Secretary
Mr. Allard is a lawyer and Member of the Quebec Bar since 1996. In addition to his position with Valeo Pharma, Mr. Allard is Vice-President, Legal Affairs and Corporate Secretary for Manitex Capital Inc. and ChitogenX Inc., two affiliates of Valeo Pharma, since April 2016. From 2007 to 2016, he was Partner and Counsel at Dentons, a multinational law firm where he specialized in corporate finance, securities, and mergers and acquisitions. Throughout his career, he has been counsel to several publicly-listed companies on various matters.
Mr. Allard holds a Bachelor's degree in Business Administration (B.A.A), a Certificate in Law and a Bachelor's degree in Law (LL.B.) from Laval University (Quebec City).
-
Dr. Jonathan Sackier
SVP, Medical Affairs
Dr. Jonathan Sackier is a physician entrepreneur with diverse contributions to the health care industry including a large surgical practice, academic work, and work in the healthcare industry as a serial entrepreneur having licensed several of his own surgical inventions. He serves, among other assignments, as SVP Medical Affairs for ChitogenX. He was a Founding Partner and Director of Computer Motion, which built the world's first surgical robot (AESOP) which then eventually merged into Intuitive Surgical to become the largest surgical robotics company in the world. Dr. Sackier has also served as a Visiting Professor at Oxford University and as a Professor at George Washington University.
Dr. Sackier holds an Mb,ChB, Medicine from Liverpool University and completed fellowships with both the Royal College of Surgeons and the American College of Surgeons
Philippe Deschamps
CEO
-
Philippe Deschamps
CEO
Philippe Deschamps is an experienced Healthcare Executive who has served as CEO of three companies over the last 20 years. The depth of his expertise stems from his 36 years in the Life Sciences industry spent at Bristol Myers Squibb, GSW Worldwide, a leading healthcare commercialization company, and Helius Medical Technologies, a NeuroTech company. As co-founder and CEO of Helius Medical Technologies, Mr. Deschamps took the company public on both the CSE, TSX and NASDAQ stock exchanges and raised $100M to commercialize their Neurotech product PoNS. The product gained approval in both Canada and the US.
At GSW, Mr. Deschamps was President and CEO and was responsible for the GSW expansion into a Worldwide operation to support the globalization of Pharma. Under his watch, revenues grew from $30M from 2 US offices in 2002 to $160M in annual revenue from 16 countries in 2011. During his tenure, he stayed heavily involved with the company's top clients and developed innovative partnerships to increase performance and save money.
Before joining GSW Worldwide, Mr. Deschamps served as director of neuroscience marketing at Bristol- Myers Squibb (BMS) in Princeton, N.J., where he oversaw the company's neuroscience products including BUSPAR SERZONE and STADOL NS. He also held several marketing positions in the neuroscience, pain and metabolic therapeutic areas throughout his career. Mr. Deschamps has a BSc. from the University of Ottawa in Canada.
Luc Mainville, MBA
SVP, CFO
-
Luc Mainville, MBA
SVP, CFO
Mr. Mainville has an accomplished history of financial and operational leadership successes within the life science industry. In an executive management career that spans more than 20 years, he has led or been integrally involved in four go-public transactions, completed more than 20 public financings, and managed more than 50 licensing, merger and acquisition, and sale transactions.
Mr. Mainville also serves as Senior Vice President and CFO for Valeo Pharma. His earlier experience includes senior management and financial roles with various life science companies, including Acerus Pharma, Cardiome Pharma, Neopharm Labs and LAB Research Inc. Prior to launching his career in the life science industry, Mr. Mainville was a Partner at KPMG LLP. Mr. Mainville has also served as Vice-Chairman of BIOTECanada and holds an MBA from McGill University.
Guy Paul Allard
VP, Legal Affairs and Corporate Secretary
-
Guy Paul Allard
VP, Legal Affairs and Corporate Secretary
Mr. Allard is a lawyer and Member of the Quebec Bar since 1996. In addition to his position with Valeo Pharma, Mr. Allard is Vice-President, Legal Affairs and Corporate Secretary for Manitex Capital Inc. and ChitogenX Inc., two affiliates of Valeo Pharma, since April 2016. From 2007 to 2016, he was Partner and Counsel at Dentons, a multinational law firm where he specialized in corporate finance, securities, and mergers and acquisitions. Throughout his career, he has been counsel to several publicly-listed companies on various matters.
Mr. Allard holds a Bachelor's degree in Business Administration (B.A.A), a Certificate in Law and a Bachelor's degree in Law (LL.B.) from Laval University (Quebec City).
Dr. Jonathan Sackier
SVP, Medical Affairs
-
Dr. Jonathan Sackier
SVP, Medical Affairs
Dr. Jonathan Sackier is a physician entrepreneur with diverse contributions to the health care industry including a large surgical practice, academic work, and work in the healthcare industry as a serial entrepreneur having licensed several of his own surgical inventions. He serves, among other assignments, as SVP Medical Affairs for ChitogenX. He was a Founding Partner and Director of Computer Motion, which built the world's first surgical robot (AESOP) which then eventually merged into Intuitive Surgical to become the largest surgical robotics company in the world. Dr. Sackier has also served as a Visiting Professor at Oxford University and as a Professor at George Washington University.
Dr. Sackier holds an Mb,ChB, Medicine from Liverpool University and completed fellowships with both the Royal College of Surgeons and the American College of Surgeons